You are here

OARSI Resources

 

OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009

By W. Zhang*, G. Nuki, R.W. Moskowitz, S. Abramson, R.D. Altman, N.K. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell

Objective: To update evidence for available therapies in the treatment of hip and knee osteoarthritis (OA) and to examine whether research evidence has changed from 31 January 2006 to 31 January 2009.

Category: Guidelines

Tags: Guidelines

 

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

By W. Zhang Ph.D., R. W. Moskowitz M.D., G. Nuki M.B., F.R.C.P.*, S. Abramson M.D., R. D. Altman M.D., N. Arden M.D., S. Bierma-Zeinstra M.Sc., Ph.D., K. D. Brandt M.D., P. Croft M.D., M. Doherty M.D., M. Dougados M.D., M. Hochberg M.D., M.P.H., D. J. Hunter

Purpose: To develop concise, patient-focussed, up to date, evidence-based, expert consensus recommendations for the management of hip and knee osteoarthritis (OA), which are adaptable and designed to assist physicians and allied health care professionals in general and specialist practise throughout the world.

Category: Guidelines

Tags: Guidelines

 

Potential sites for kinetic drug-drug interactions

By Patrick du Souich

Category: Biomarkers

Tags: Therapy

 

Epidemiology of OA

By S Chubinskaya

Category: Biomarkers

Tags: Epidemiology

 

Challenges in Studying Risk Factors for OA Progression

By Yuqing Zhang, DSc

Category: Biomarkers

Tags: Epidemiology